Dry eye disease treatment improves subjective quality-of-life responses in patients with AMD, independent of disease stage
Managing DED improved quality of life (QOL) in patients with AMD, regardless of retinal disease severity. This highlights the importance of treating coexisting ocular surface conditions to enhance patient outcomes, even in the presence of significant maculopathy.
Authors
- Nehal Nailesh Mehta (ORCID: https://orcid.org/0000-0003-4653-2021)
- Anna Heinke (ORCID: https://orcid.org/0000-0002-7115-8767)
- Akshay Agnihotri (ORCID: https://orcid.org/0009-0001-4624-8250)
- Lingyun Cheng (ORCID: https://orcid.org/0000-0002-0748-5173)
- Maria-Laura Gomez (ORCID: https://orcid.org/0000-0003-2908-8096)
- Ines Doris Nagel (ORCID: https://orcid.org/0000-0002-4649-6764)
- Dirk-Uwe Bartsch
- W. R. Freeman
Institutions
- University of California San Diego (US)
- The Retina Center (US)
- Jacobs (United States) (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1371/journal.pone.0318733
- Citations
- 4
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 7.51
Funders
- Research to Prevent Blindness
- National Institutes of Health
- University of California, San Diego